...
首页> 外文期刊>The Journal of biological chemistry >The Crystal Structure of the Leishmania major Deoxyuridine Triphosphate Nucleotidohydrolase in Complex with Nucleotide Analogues, dUMP, and Deoxyuridine
【24h】

The Crystal Structure of the Leishmania major Deoxyuridine Triphosphate Nucleotidohydrolase in Complex with Nucleotide Analogues, dUMP, and Deoxyuridine

机译:Leishmania主要脱氧尿苷的晶体结构与核苷酸类似物,倾荷和脱氧尿苷中的复合物中的三磷酸核苷酸酶

获取原文

摘要

Members of the Leishmania genus are the causative agents of the life-threatening disease leishmaniasis. New drugs are being sought due to increasing resistance and adverse side effects with current treatments. The knowledge that dUTPase is an essential enzyme and that the all α-helical dimeric kinetoplastid dUTPases have completely different structures compared with the trimeric β-sheet type dUTPase possessed by most organisms, including humans, make the dimeric enzymes attractive drug targets. Here, we present crystal structures of the Leishmania major dUTPase in complex with substrate analogues, the product dUMP and a substrate fragment, and of the homologous Campylobacter jejuni dUTPase in complex with a triphosphate substrate analogue. The metal-binding properties of both enzymes are shown to be dependent upon the ligand identity, a previously unseen characteristic of this family. Furthermore, structures of the Leishmania enzyme in the presence of dUMP and deoxyuridine coupled with tryptophan fluorescence quenching indicate that occupation of the phosphate binding region is essential for induction of the closed conformation and hence for substrate binding. These findings will aid in the development of dUTPase inhibitors as potential new lead anti-trypanosomal compounds.
机译:Leishmania属的成员是威胁危及生命疾病的致病因子Leishmaniaisis。由于目前治疗的抗性和不良副作用,正在寻求新药。抑制抑制酶是必需酶的知识,并且所有α-螺旋二聚体酮抑制抑制酶与大多数生物(包括人类)所拥有的三聚β-片型含义,使其具有完全不同的结构,使二聚体酶具有吸引力的药物靶标。在此,我们将Leishmania主要utpase的晶体结构呈现在与底物类似物,产物转储和底物片段的复合物中,以及与三磷酸底物类似物的复合物中的同源弯曲杆菌朱膦酶。两种酶的金属结合特性显示依赖于配体同一性,该家庭的先前看不见的特征。此外,与色氨酸荧光猝灭偶联的倾脱和脱氧尿苷存在的Leishmania酶的结构表明磷酸盐结合区域的占用对于诱导闭合构象并因此是底物结合是必不可少的。这些发现将有助于抑制utPase抑制剂作为潜在的新铅抗促蛋白酶体化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号